Add to ORKGThis is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited. Open Access Full open access to this and thousands of other papers a
Objective/Background A reasonable incidence of tuberculo-sis (TB) still occurs in the United Kingdom...
AbstractIsoniazid (INH) is highly effective for the management of tuberculosis. However, it can caus...
Treatment of latent Mycobacterium tuberculosis infection with isoniazid can cause hepatotoxicity, bu...
This paper describes a case of an acute and fatal isoniazid-induced hepatotoxicity and provides a re...
Isoniazid (INH) monotherapy has gained widespread acceptance as an efficacious therapy for latent tu...
Recent increases in the dosages of the essential antituberculosis agents isoniazid (INH), rifampicin...
Isoniazid (INH) is a synthetic anti-mycobacterial agent used to treat active or latent tuberculosis ...
Contains fulltext : 69857.pdf (publisher's version ) (Closed access)The cornerston...
Tuberculosis (TB) is a chronic bacterial infection caused by Mycobacterium tuberculosis complex, mos...
The information provided in this handout does not necessarily reflect the views of the University of...
Approximately one-third of the world's population harbors the tuberculosis mycobacterium and it is ...
The prevalence of latent tuberculosis infection (LTBI) in the United States in 2011 and 2012 was est...
Isoniazid and pyrazinamide are both well-known hepatotoxic drugs. When isoniazid is used, the hepati...
ABSTRACT According to WHO, one third of the population is affected by TB and 1 in 4 adult male deat...
Tuberculosis (TB) is a great health problem worldwide,and the most effective control method is to cu...
Objective/Background A reasonable incidence of tuberculo-sis (TB) still occurs in the United Kingdom...
AbstractIsoniazid (INH) is highly effective for the management of tuberculosis. However, it can caus...
Treatment of latent Mycobacterium tuberculosis infection with isoniazid can cause hepatotoxicity, bu...
This paper describes a case of an acute and fatal isoniazid-induced hepatotoxicity and provides a re...
Isoniazid (INH) monotherapy has gained widespread acceptance as an efficacious therapy for latent tu...
Recent increases in the dosages of the essential antituberculosis agents isoniazid (INH), rifampicin...
Isoniazid (INH) is a synthetic anti-mycobacterial agent used to treat active or latent tuberculosis ...
Contains fulltext : 69857.pdf (publisher's version ) (Closed access)The cornerston...
Tuberculosis (TB) is a chronic bacterial infection caused by Mycobacterium tuberculosis complex, mos...
The information provided in this handout does not necessarily reflect the views of the University of...
Approximately one-third of the world's population harbors the tuberculosis mycobacterium and it is ...
The prevalence of latent tuberculosis infection (LTBI) in the United States in 2011 and 2012 was est...
Isoniazid and pyrazinamide are both well-known hepatotoxic drugs. When isoniazid is used, the hepati...
ABSTRACT According to WHO, one third of the population is affected by TB and 1 in 4 adult male deat...
Tuberculosis (TB) is a great health problem worldwide,and the most effective control method is to cu...
Objective/Background A reasonable incidence of tuberculo-sis (TB) still occurs in the United Kingdom...
AbstractIsoniazid (INH) is highly effective for the management of tuberculosis. However, it can caus...
Treatment of latent Mycobacterium tuberculosis infection with isoniazid can cause hepatotoxicity, bu...